Revenue: The sum of all revenue fields included for a company's operating activities.
Neuphoria Therapeutics Inc. (NEUP) Revenue data is not available for the most recently reported fiscal year, ending 2024-06-30.
| Income Statement Financials | |
|
Revenue |
-- |
$-15.49M |
|
-- |
|
-- |
|
$17.89M |
|
$-17.89M |
|
$2.31M |
|
$-15.58M |
|
$-15.58M |
|
$-15.49M |
|
$-15.49M |
|
$-15.49M |
|
$-15.49M |
|
$-17.89M |
|
$-17.23M |
|
0.83M |
|
0.83M |
|
$-18.62 |
|
$-18.62 |
|
| Balance Sheet Financials | |
$13.19M |
|
$0.00M |
|
$14.46M |
|
$27.65M |
|
$3.83M |
|
-- |
|
$6.33M |
|
$10.16M |
|
$17.49M |
|
$3.33M |
|
$17.49M |
|
1.10M |
|
| Cash Flow Statement Financials | |
$-14.68M |
|
-- |
|
$15.11M |
|
$12.18M |
|
$12.69M |
|
$0.51M |
|
$0.81M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.45 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-14.68M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-88.58% |
|
-464.83% |
|
-56.03% |
|
-88.58% |
|
$15.85 |
|
$-17.65 |
|
$-17.65 |
|